SEC Filing Details
Document Details
Form
Filing Date
Sep 18, 2024
Document Date
Sep 17, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Akari Therapeutics
Issuer
AKARI THERAPEUTICS PLC
Filer
Bazemore Robert B
